设计一个αCD206-synNotch受体:对新型合成受体开发的见解
Sofija Semeniuk1,2, Bin-Zhi Qian3, Elise Cachat1,2
1Centre for Engineering Biology, University of Edinburgh, Edinburgh EH9 3BF, United Kingdom.
ACS synthetic biology
|November 18, 2024
概括
研究人员使用合成生物学开发了一种新工具,用于研究癌细胞和CD206阳性巨细胞之间的相互作用,这对于理解和监测癌症转移至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 合成生物学 合成生物学
背景情况:
- 免疫细胞,特别是巨细胞,显著影响瘤的进展和转移.
- 了解癌细胞-巨细胞相互作用至关重要,但目前的研究工具有限.
- CD206阳性巨细胞是促进转移生长的关键参与者.
研究的目的:
- 开发一种新的合成受体 (synNotch) 来准和研究CD206阳性巨细胞.
- 用这种受体对癌细胞进行工程设计,以监测瘤微环境中的相互作用.
- 调查这些相互作用在转移建立中的作用.
主要方法:
- 癌症"登陆板"细胞的开发,用于多样化的应用.
- 将alpha-CD206 synNotch受体工程到癌细胞中.
- 在小鼠转移模型中测试工程细胞的活性和特异性.
主要成果:
- 成功设计了表达alpha-CD206 synNotch受体的癌细胞.
- 展示该工具在研究癌细胞与巨细胞相互作用方面的潜力.
- 在体内应用中识别出意外的挑战.
结论:
- 开发的alpha-CD206 synNotch癌细胞为研究巨细胞-癌细胞动态提供了一个新的工具.
- 这种方法可以提供对转移机制的见解.
- 需要进一步的研究来克服体内应用的警告.
关键词:
CD206 是一个CD206 CD206 是一个CD206 CD206交叉反应性 交叉反应性巨细胞是什么?巨细胞是什么?转移 转移 转移 转移SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch SynNotch synNotch synNotch synNotch synNotch synNotch synNotch synNotch synNotch合成受体是一种合成受体.相关概念视频
Assembly of Signaling Complexes
5.7K
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
5.7K
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
Diversity of Antigen Receptors
527
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
527
Transducer Mechanism: G Protein–Coupled Receptors
1.9K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
1.9K


